Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial.

Ghanbari F, Reddy YNV, Packer M, Ng A, Carter R, Jensen MD, Leiner T, Borlaug BA

Open source

DOI
10.1038/s41591-026-04787-8
Published
2026 Nov 8
Container
Nature medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04787-8,
  title = {Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial.},
  author = {Ghanbari F and Reddy YNV and Packer M and Ng A and Carter R and Jensen MD and Leiner T and Borlaug BA},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04787-8},
  url = {https://doi.org/10.1038/s41591-026-04787-8}
}

RIS

TY  - JOUR
TI  - Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial.
AU  - Ghanbari F
AU  - Reddy YNV
AU  - Packer M
AU  - Ng A
AU  - Carter R
AU  - Jensen MD
AU  - Leiner T
AU  - Borlaug BA
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04787-8
UR  - https://doi.org/10.1038/s41591-026-04787-8
ER  - 

APA

F, G., YNV, R., M, P., A, N., R, C., MD, J., T, L., & BA, B. (2026). Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04787-8

Source records